Journal
MICROCHIMICA ACTA
Volume 185, Issue 1, Pages -Publisher
SPRINGER WIEN
DOI: 10.1007/s00604-017-2598-0
Keywords
Doxorubicin; CD-44; Photoluminescence; Forster resonance energy transfer; HeLa; Nanoparticles; Nanocarrier; Fluorescence quenching; Target recognition; Drugs loading
Categories
Funding
- National Natural Science Foundation of China [21075050, 21005029]
Ask authors/readers for more resources
The authors describe new bifunctional mesoporous silica nanoparticles (NPs) for specific targeting of tumor cells and for intracellular delivery of the cancer drug doxorubicin (DOX). Mesoporous silica nanoparticles (MSNPs) were coated with blue fluorescent N-graphene quantum dots, loaded with the drug DOX, and finally coated with hyaluronic acid (HA). Cellular uptake of the NPs with an architecture of the type HA-DOX-GQD@MSNPs enabled imaging of human cervical carcinoma (HeLa) cells via fluorescence microscopy. The cytotoxicity of the nanoparticles on HeLa cells was also assessed. The results suggest that the NPs are higher cytotoxicity effect and exert in living cell imaging ability. Compared to the majority of other drug nanocarrier systems, the one described here enables simultaneous DOX release and fluorescent monitoring.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available